Bone/Mineral Metabolism News

Absolute appendicular lean mass appears to be a suitable marker for predicting osteoporosis based on low muscle mass for postmenopausal women, according to findings published in Menopause.

Treating to a vitamin D level of at least 30 ng/mL is associated with significantly lower risk for myocardial infarction and all-cause mortality among adults with no prior MI history, according to an analysis of Veterans Affairs data.

It will be “many years” before any new pharmacologic osteoporosis therapies are approved, as there are currently no new drugs in phase 2 or 3 development, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.

Among adults with differentiated thyroid cancer on thyroid-stimulating hormone suppression therapy, postmenopausal women had lower bone mineral density at the lumbar spine whereas premenopausal women had greater BMD vs. healthy controls.

Just one-third of women older than 65 years were screened for osteoporosis at an internal medicine clinic, and one-third of those diagnosed were untreated, noted a speaker at the 2021 North American Young Rheumatology Investigator Forum.

An annual infusion of zoledronic acid can help attenuate bone loss in adults with acute spinal cord injury, according to a study published in the Journal of Bone and Mineral Research.

Patients with rheumatoid arthritis who receive even low daily doses of glucocorticoids are at a 59% increased risk for clinical vertebral fracture, according to data published in Rheumatology.

There is a bidirectional relationship between cognitive decline and accelerated bone loss with increased fracture risk among women, according to new data published in the Journal of Bone and Mineral Research.

Postmenopausal women with osteoporosis receiving romosozumab for 12 months had larger improvements in bone mineral density and bone strength at the lumbar spine compared with those receiving alendronate alone, according to study data.

Adults prescribed any oral anticoagulation therapy have lower bone mineral density and trabecular bone score compared with controls, with a stronger negative effect observed among those prescribed warfarin, data published in Bone show.